Predictors of Virological Response to a Combination Therapy with Pegylated Interferon Plus Ribavirin Including  Virus and Host Factors

<table>Number of ISDR substitutions and the comparison of virological response, SVR, and relapse at the end of the treatment. Compared with the patients with 2 or more sites of substitutions, the rate of SVR was lower and the rate of relapse was higher in the patients in whom there were fewer substitutions in ISDR, that is, 0 or 1 sites.</table>

Hepatitis Research and Treatment

fig3

Figure 3

Figure 3: Predictors of Virological Response to a Combination Therapy with Pegylated Interferon Plus Ribavirin Including  Virus and Host Factors 